Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
Go back to Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting| TELEFLEX INCORPORATED (NYSE: TFX) | Delayed: 121.67 -5.33 (4.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.00 | 52 Week High | $188.79 | |||
| Open | $126.43 | 52 Week Low | $125.28 | |||
| Day High | $126.43 | P/E | 35.16 | |||
| Day Low | $120.86 | EPS | $3.46 | |||
| Volume | 722,670 | |||||
